With Over $1 Billion Invested, PCI Pharma Services Expands Sterile Fill-Finish Manufacturing and Drug-Device Combination Capabilities

With Over $1 Billion Invested, PCI Pharma Services Expands Sterile Fill-Finish Manufacturing and Drug-Device Combination Capabilities

A world-leading, integrated global contract development and manufacturing organization (CDMO) focused on innovative biologics and small molecule therapies, announced a series of significant infrastructure investments that will substantially enhance its…

Read MoreWith Over $1 Billion Invested, PCI Pharma Services Expands Sterile Fill-Finish Manufacturing and Drug-Device Combination Capabilities
Kyocera Develops Breakthrough Multilayer Ceramic Core Substrate for Advanced AI Semiconductors

Kyocera Develops Breakthrough Multilayer Ceramic Core Substrate for Advanced AI Semiconductors

Kyocera Corporation (President: Shiro Sakushima; “Kyocera”) today announced that it is commercializing a new multilayer ceramic core substrate for advanced semiconductor packages, such as xPUs(1) and switch ASICs, which are rapidly scaling in complexity as…

Read MoreKyocera Develops Breakthrough Multilayer Ceramic Core Substrate for Advanced AI Semiconductors
PCI Pharma Services Unveils Major U.S. Expansion in Sterile Fill-Finish and Drug-Device Capabilities, Supported by Over $1 Billion in Investments

PCI Pharma Services Unveils Major U.S. Expansion in Sterile Fill-Finish and Drug-Device Capabilities, Supported by Over $1 Billion in Investments

A world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its…

Read MorePCI Pharma Services Unveils Major U.S. Expansion in Sterile Fill-Finish and Drug-Device Capabilities, Supported by Over $1 Billion in Investments